GlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2023 Earnings Call Tran

Operator: Good morning, and thank you for joining the GlycoMimetics Q4 and Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Related Keywords

United States , American , Tara Bancroft , Christian Dinneen , Bruce Johnson , Brian Hahn , Harout Semerjian , Naureen Quibria , Children Oncology Group Phase , Company Counsel At Glycomimetics , Glycomimetics Inc , Pediatric Early Phase Clinical Trial Network , Nasdaq , Dana Farber Cancer Institute , American Cancer Society , National Cancer Institute , Alliance For Clinical Trials In Oncology , American Society Of Hematology Research Collaborative , Call Transcript March , Full Year , Christian Dinneen Long , Company Counsel , Chief Executive Officer , Chief Financial Officer , Edwin Rock , Chief Medical Officer , Chief Commercial , Clinical Trials , Early Phase Clinical Trial , American Society , Hematology Research , Wall Street Lower Ratings , Capital One ,